# Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer

> **NCT00212082** · PHASE2 · COMPLETED · sponsor: **National University Hospital, Singapore** · enrollment: 100 (—)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** doxorubicin, docetaxel

## Key facts

- **NCT ID:** NCT00212082
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212082, "Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00212082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*